Key result
Synthetic elastic protein induces elastin synthesis and decreases aortic wall stiffness in elastin-haploinsufficient mice.
Why the study?
Alteration of elastic fibers causes cardiovascular dysfunction in elastin haploinsufficiency, prompting evaluation of a synthetic elastic protein mimicking tropoelastin domains as a potential treatment.
Does a synthetic elastic protein (SEP) improve arterial structure and function in elastin-haploinsufficient mice?
Population
Eln+/+ and Eln+/- male and female mice and cultured aortic smooth muscle cells
Comparison
Treatment with synthetic elastic protein vs untreated controls
Design
Preclinical animal and cell culture study
Authors
Loading...
Hypothesis-generating for SEP in elastin-deficient vasculopathy; human translation remains untested.
Does a synthetic elastic protein (SEP) improve arterial structure and function in elastin-haploinsufficient mice?
A synthetic elastic protein shows potential as a biomimetic treatment to improve arterial structure and function in elastin-deficient conditions.
Boëté et al. (2022) studied Elastin haploinsufficiency. Synthetic elastic protein (SEP) was evaluated on Aortic structure and function (elastin synthesis, wall stiffness, vasodilatory response). Treatment with a synthetic elastic protein induced elastin synthesis, thickened aortic elastic lamellae, and decreased wall stiffness in elastin-haploinsufficient mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: